LIFECORE BIOMEDICAL, INC. \DE\ Insider Trading Activity
Every SEC Form 4 insider transaction reported for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are LFCR insiders buying or selling?
LIFECORE BIOMEDICAL, INC. \DE\ insiders reported no open-market purchases or sales in the last 12 months. Since April 2018, Trabud has recorded 56 Form 4 filings for LFCR: 47 buys ($27.0M) and 9 sells ($10.3M).
Source: SEC EDGAR Form 4
Key Statistics (April 2018 – May 29, 2025)
Total Form 4 filings
56
SEC EDGAR
Insider filers
17
Insider buys (47)
$27.0M
Insider sells (9)
$10.3M
Insider sentiment
Net buyingNet insider flow of $16.8M in net buying since April 2018.
Recent LFCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | Aron R. English | 10% Owner | Sale | 1.4M | $6.59 | $9.1M | SEC ↗ |
| May 16, 2025 | Aron R. English | 10% Owner | Sale | 12.3K | $7.00 | $86.4K | SEC ↗ |
| May 12, 2025 | Aron R. English | 10% Owner | Sale | 51.5K | $7.03 | $362.0K | SEC ↗ |
| May 8, 2025 | Aron R. English | 10% Owner | Sale | 41.1K | $7.05 | $289.9K | SEC ↗ |
| Jan 8, 2025 | Paul Josephs | Chief Executive Officer | Purchase | 17.0K | $5.74 | $97.6K | SEC ↗ |
| Oct 8, 2024 | Nelson Obus | 10% Owner | Purchase | 292.7K | $4.10 | $1.2M | SEC ↗ |
| Oct 7, 2024 | Christopher S Kiper | Director, 10% Owner | Purchase | 1.5M | $4.10 | $6.0M | SEC ↗ |
| Jan 18, 2023 | Nelson Obus | 10% Owner | Purchase | 627.7K | $7.97 | $5.0M | SEC ↗ |
| Oct 26, 2022 | Nelson Obus | 10% Owner | Purchase | 250.0K | $8.09 | $2.0M | SEC ↗ |
| Jan 14, 2022 | Nelson Obus | 10% Owner | Purchase | 387.4K | $10.41 | $4.0M | SEC ↗ |
| Jan 14, 2022 | Joshua Schechter | Director | Purchase | 10.0K | $10.39 | $103.9K | SEC ↗ |
| Apr 22, 2021 | Patrick D Walsh | Director | Purchase | 10.0K | $11.26 | $112.6K | SEC ↗ |
| Apr 21, 2021 | Timothy P Burgess | Senior VP of Supply Chain | Purchase | 5.0K | $9.99 | $50.4K | SEC ↗ |
| Apr 20, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.05 | $22.1K | SEC ↗ |
| Apr 19, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.08 | $22.2K | SEC ↗ |
| Apr 16, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.98 | $22.0K | SEC ↗ |
| Apr 15, 2021 | Albert D. Bolles | Chief Executive Officer | Purchase | 9.0K | $10.61 | $95.5K | SEC ↗ |
| Apr 15, 2021 | James G Hall | Vice President | Purchase | 10.0K | $10.62 | $106.2K | SEC ↗ |
| Apr 15, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.64 | $21.3K | SEC ↗ |
| Apr 15, 2021 | Nelson Obus | 10% Owner | Purchase | 240.6K | $10.02 | $2.4M | SEC ↗ |
| Apr 14, 2021 | Nelson Obus | 10% Owner | Purchase | 240.6K | $10.02 | $2.4M | SEC ↗ |
| Apr 13, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $10.18 | $20.4K | SEC ↗ |
| Feb 12, 2021 | John D Morberg | Chief Financial Officer | Purchase | 1.4K | $11.88 | $16.6K | SEC ↗ |
| Feb 11, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $11.64 | $23.3K | SEC ↗ |
| Feb 10, 2021 | John D Morberg | Chief Financial Officer | Purchase | 2.0K | $12.06 | $24.1K | SEC ↗ |
Showing the 25 most recent of 56 Form 4 filings for LIFECORE BIOMEDICAL, INC. \DE\.
Most active LFCR insiders
- Nelson Obus16 filings
- John D Morberg10 filings
- Nelson Obus6 filings
- Ronald Lane Midyett5 filings
- Aron R. English4 filings
Ask anything about LFCR insider activity
Use Trabud's AI agent to query LIFECORE BIOMEDICAL, INC. \DE\'s Form 4 history in plain English — "Show me LFCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentLFCR insider trading FAQ
Are LIFECORE BIOMEDICAL, INC. \DE\ insiders buying or selling?
LIFECORE BIOMEDICAL, INC. \DE\ insiders reported no open-market purchases or sales in the last 12 months. Since April 2018, Trabud has recorded 56 Form 4 filings for LFCR: 47 buys ($27.0M) and 9 sells ($10.3M). Over the full record that is net buying of $16.8M.
How many insiders trade LFCR stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for LIFECORE BIOMEDICAL, INC. \DE\. The most recent filing was accepted on May 29, 2025.
Where does Trabud get LFCR insider trading data?
All LFCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.